These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8039304)

  • 41. Defining the invasive phenotype of proximal gastric cancer cells.
    Schwartz GK; Wang H; Lampen N; Altorki N; Kelsen D; Albino AP
    Cancer; 1994 Jan; 73(1):22-7. PubMed ID: 8275429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
    Hur JH; Park MJ; Park IC; Yi DH; Rhee CH; Hong SI; Lee SH
    J Korean Med Sci; 2000 Jun; 15(3):309-14. PubMed ID: 10895974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of tissue inhibitor of metalloproteinase-1 and type IV collagenase/gelatinase messenger RNAs in human breast cancer.
    Lindsay CK; Thorgeirsson UP; Tsuda H; Hirohashi S
    Hum Pathol; 1997 Mar; 28(3):359-66. PubMed ID: 9042802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells.
    Ginestra A; Monea S; Seghezzi G; Dolo V; Nagase H; Mignatti P; Vittorelli ML
    J Biol Chem; 1997 Jul; 272(27):17216-22. PubMed ID: 9202045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
    BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-1 beta induces differential gene expression in aortic smooth muscle cells.
    Keen RR; Nolan KD; Cipollone M; Scott E; Shively VP; Yao JS; Pearce WH
    J Vasc Surg; 1994 Nov; 20(5):774-84; discussion 784-6. PubMed ID: 7966813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
    Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW
    Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.
    Uhm JH; Dooley NP; Villemure JG; Yong VW
    Clin Exp Metastasis; 1996 Oct; 14(5):421-33. PubMed ID: 8871536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
    Blaser J; Triebel S; Maasjosthusmann U; Romisch J; Krahl-Mateblowski U; Freudenberg W; Fricke R; Tschesche H
    Clin Chim Acta; 1996 Jan; 244(1):17-33. PubMed ID: 8919199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
    Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.
    Rao JS; Yamamoto M; Mohaman S; Gokaslan ZL; Fuller GN; Stetler-Stevenson WG; Rao VH; Liotta LA; Nicolson GL; Sawaya RE
    Clin Exp Metastasis; 1996 Jan; 14(1):12-8. PubMed ID: 8521611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity.
    Tsuboi R; Rifkin DB
    Int J Cancer; 1990 Jul; 46(1):56-60. PubMed ID: 2142142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080.
    Tanaka K; Iwamoto Y; Ito Y; Ishibashi T; Nakabeppu Y; Sekiguchi M; Sugioka Y
    Cancer Res; 1995 Jul; 55(13):2927-35. PubMed ID: 7796421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Gene expressions of type IV collagenase and tissue inhibitor of metalloproteinases (TIMP) in human bladder cancers].
    Naruo S; Kanayama H; Aki M; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1993 May; 84(5):841-50. PubMed ID: 8320889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2.
    Deryugina EI; Luo GX; Reisfeld RA; Bourdon MA; Strongin A
    Anticancer Res; 1997; 17(5A):3201-10. PubMed ID: 9413149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Increased expression of gelatinases A and B, matrilysin and TIMP-1 genes in human malignant gliomas ].
    Nakano A; Tani E; Yamamoto Y; Furuyama J; Miyazaki K
    Nihon Rinsho; 1995 Jul; 53(7):1816-21. PubMed ID: 7630025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.
    Baricos WH; Cortez SL; el-Dahr SS; Schnaper HW
    Kidney Int; 1995 Apr; 47(4):1039-47. PubMed ID: 7540230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.
    Wang M; Fudge K; Rhim JS; Stearns ME
    Oncol Res; 1996; 8(7-8):303-15. PubMed ID: 8938794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.
    Netzel-Arnett S; Mitola DJ; Yamada SS; Chrysovergis K; Holmbeck K; Birkedal-Hansen H; Bugge TH
    J Biol Chem; 2002 Nov; 277(47):45154-61. PubMed ID: 12192005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
    Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.